Antimicrobial peptides (AMPs) are produced by a range of organisms as a first line of defense against invaders or competitors. Owing to their broad antimicrobial activity, AMPs have attracted attention as a potential source of chemotherapeutic drugs. The increasing prevalence of infections caused by Candida species as opportunistic pathogens in immunocompromised patients requires new drugs. Lecythis pisonis is a Lecythydaceae tree that grows in Brazil. The AMPs produced by this tree have not been described previously. We describe the isolation of 12 fractions enriched in peptides from L. pisonis seeds. Of the 12 fractions, at 10 μg/ml, the F4 fraction had the strongest growth inhibitory effect (53.7%) in Candida albicans, in addition to a loss of viability of 94.9%. The F4 fraction was separated into seven sub-fractions by reversed-phase chromatography. The F4.7′ fraction had the strongest activity at 10 μg/ml, inhibiting C. albicans growth by 38.5% and a 69.3% loss of viability. The peptide in F4.7′ was sequenced and was found to be similar to plant defensins. For this reason, the peptide was named L. pisonis defensin 1 (Lp-Def 1 ). The mechanism of action that is responsible for C. albicans inhibition by Lp-Def 1 includes a slight increase of reactive oxygen species induction and a significant loss of mitochondrial function. The results described here support the future development of plant defensins, specifically Lp-Def 1 , as new therapeutic substances against fungi, especially C. albicans.
Introduction
Antimicrobial peptides (AMPs) are molecules produced by a range of organisms, from bacteria to mammals, and constitute a first line of defense against invaders or competitors [1, 2] . AMPs are short polymers of L-amino acids and usually range in size from ∼13 to 100 amino acid residues [3] . Despite their small size, they present great variation at the different levels of protein organizational structure [4] . In addition to this huge structural variation, they share some common features, such as short size, amphipathicity, a typically high isoelectric point (they are positively charged in neutral pH), and antimicrobial activity against different species of entities, such as viruses, Gram-positive and Gram-negative bacteria, fungi, parasitic protozoa, and even some tumor cell lines [1, 5] .
The broad spectrum of antimicrobial activity presented by AMPs has attracted attention as a possible new source of chemotherapeutic drugs [6] . They have the potential to fulfill different requirements in our industrialized world, e.g. to offset the increased bacterial resistance to classic antibiotics [7] , including tuberculosis [8] , and as new drugs to treat neglected diseases [9] .
In addition to these public health problems, the prevalence of infections caused by yeasts of the genus Candida as opportunistic pathogens is increasing [10] [11] [12] [13] [14] . The yeasts of the Candida genus are commensal organisms that reside in the gastrointestinal, respiratory, urinary, and reproductive systems of healthy humans [11] . However, situations of immune system compromise, such as advanced age, immunosuppression (cancer, acquired immunodeficiency syndrome, and transplant patients) as well as burns, invasive surgery, prolonged internment time in intensive care units and antibiotic treatment, provoke an imbalance in the relationships of the human host, inducing the transition of a commensal organism to an opportunistic pathogenic one. Infections can range from skin and mucosal disorders to invasive mycoses that affect internal organs [10, [12] [13] [14] . In addition, some cases in which clinical Candida albicans strains became resistant to antifungals such as amphotericin B and fluconazole have been reported [15, 16] , thus amplifying the problems described above and increasing the urgency of the developing new chemotherapeutic substances.
In plants, several AMPs belonging to different families have been characterized. Based on their primary structure, number and paring of cysteine residues, and secondary and tertiary structure, they were grouped into plant defensins [17] , lipid transfer proteins [18] , cyclotides [19] , thionins [20] , hevein-like peptides, knottin-like peptides, glycine-rich peptides [2, 21] , MBP-1 [22] , snakins [23] , and some proteinase inhibitor families [24] . However, AMPs from trees have not been well studied. A few exceptions are Pinus sylvestris (scots pine) [25] , Elaeis guineesins (oil palm) [26] , Prunus persica ( peach) [27, 28] , Ginkgo biloba [29, 30] , Pandanus amaryllifolius [31] , and Picea abeis (Norway spruce) [32] . These few examples are restricted to plants that are of economic interest. For wild species, almost no research is available in the specialized literature.
Lecythis pisonis (sapucaia) is a wild tree that belongs to the Lecythydaceae family. This species occurs in Brazil, from Amazon to Atlantic forest biomes [33] . Its seed is rich in fatty acids, particularly linoleic and oleic acids; proteins, which are rich in essential amino acids; fiber; and minerals, such as phosphorus, potassium, magnesium, and calcium [34] [35] [36] . Anti-nutritional factors, such as proteinase inhibitors, lectins, and tannins, were not observed [35] . Based on these nutritional features, the seeds of L. pisonis have the potential to be utilized as food by humans. However, there is no information about the AMPs of L. pisonis.
Fungal infections caused by opportunistic pathogens, such as the Candia genus, are a serious medical issue. Because AMPs have not been previously characterized in L. pisonis, the aim of this study was to investigate the presence of AMPs in this arboreal species of Brazilian flora and to survey their inhibitory activity against C. albicans as an innovative therapeutic drug.
Materials and Methods

Seeds and cells
Lecythis pisonis Cambess (sapucaia) seeds were collected from wild trees in the province of São José de Ubá-RJ, Brazil, during August and September 2012. The seeds were maintained in closed flasks at room temperature until use.
Candida albicans (CE022, obtained from Universidade Federal do Ceará, http://www.cemm-ufc.org/#!micoteca/cjiy) cells were grown in Petri dishes in Sabouraud agar (Merck Millipore Brazil, São Paulo, Brazil) containing 5 g/l peptone from meat, 5 g/l peptone from casein, 20 g/ l D(+)glucose, and 15 g/l agar, for 48 h at 30°C. The Petri dishes were then stored at 4°C for 1 week and a new culture was started weekly.
All reagents were purchased from Sigma-Aldrich Brazil (São Paulo, Brazil) excepted where indicated.
Peptide extraction and partial purification
The cotyledons of L. pisonis (0.5 g) seeds were ground in liquid nitrogen. The flour had its fat removed by being stirred for 1 h in petroleum ether (1:30, p/v). After petroleum ether removal, the peptides were extracted for 1 h in the extraction buffer containing 1% trifluoroacetic acid (TFA), 1 M HCl, 5% formic acid, and 1% NaCl as described previously [37] . The extract was centrifuged at 18,000 g for 10 min at 4°C, and the supernatant was stored at −20°C.
The supernatant was filtered through Millex-GV 0.22 μm poly(vinylidene fluoride) membrane (Merck Millipore Brazil) and applied to a C18 reversed-phase (Shim-pack VP-ODA 250Lx4.6, Shimadzu do Brazil, São Paulo, Brazil) HPLC column (Prominence; Shimadzu do Brazil) coupled to a C8 column (Pelliguard; Sigma-Aldrich) equilibrated with solvent A (0.1% TFA in ultra-pure water). The protein fractions were eluted from the column by a linear gradient of 2-propanol (LiChrosolv; Merck Millipore Brazil) as follows: from 0 to 8 min, 0% solvent B (100% 2-propanol and 0.1% TFA); from 8 to 18 min, 0%-15% of solution B; from 18 to 60 min, 15%-34% of solution B; from 60 to 66 min, 34%-65% of solution B; and from 66 to 80 min, the concentration of solution B was decreased to 0% until the end of the run. The elution profile was monitored by absorbance at 220 ± 4 nm. All fractions were concentrated by freezedrying (K105; Liotop, São Paulo, Brazil). The fractions were collected differentially based on the increase and decline of the absorbance of the largest peaks.
Peptide final purification and protein quantitation
The fraction with the strongest activity against C. albicans was chosen for further purification. This fraction was applied to the same C18 column with a newly developed and extended gradient based on a percentage of the 2-propanol gradient of the first chromatographic step. The gradient was as follows: from 0 to 12 min, 0% solution B (100% 2-propanol and 0.1% TFA); from 12 to 27 min, 0%-16% of solution B; from 27 to 140 min, 16%-20% of solution B; from 140 to 143 min, 20%-50% of solvent B; from 143 to 144 min, 50% of solution B; and from 144 to 150 min, the concentration of solution B was decreased to 0% until the end of the run. Samples were eluted and concentrated as before. The fractions were collected differentially based on the increase and decline of the absorbance of the largest peaks.
The completely freeze-dried samples were re-suspended in 30 µl of ultra-pure water and had their protein content quantified by the method described by Bradford [38] or by the bicinchoninic acid method, as described by the manufacturer (Technical Bulletin B9643; SigmaAldrich). In both cases, a standard curve was built using albumin from chicken egg white.
An estimated quantitation was also made by visual comparison of the protein band of interest with a standard curve of known concentrations of lysozyme by tricine gel electrophoresis [39] .
These samples were also used for following gel electrophoresis and growth inhibition assay.
Gel electrophoresis
Protein analyses were performed as described previously [39] . Prior electrophoresis, fractions (∼4 µl of each sample per lane) were reduced by boiling them in sample buffer (0.1 M Tris-HCl, pH 8.0, 2% SDS, 10% sucrose, and 0.25% bromophenol blue containing 5% β-mercaptoethanol). After electrophoresis, the gels were stained with Coomassie Brilliant Blue R-250 or detected by silver staining. Protein markers (19, 950, 14, 440, 10, 600, 8160, 6210, 3480 , and 2510 Da) of the MW-SDS-17S kit (Sigma-Aldrich) were used as standards according to the instruction manual.
Growth inhibition assay
Candida albicans cells were grown in Petri dishes in Sabouraud agar for 48 h at 30°C. One colony was transferred to 1 ml of Sabouraud broth (5 g/l peptone from meat, 5 g/l peptone from casein, and 20 g/l D(+)glucose) (Merck Millipore Brazil) and then diluted (1:100). Cell numbers were determined by cell counting in a Neubauer chamber (Optik Labor, Lancing, UK) under an Axioplan.A2 optical microscope (Carl Zeiss do Brazil, São Paulo, Brazil). Peptide fractions were freeze-dried and then re-suspended in ultra-pure water. The protein content was quantified. The assay was performed in a Nunc 96-well microplate (Thermo Scientific Brazil, São Paulo, Brazil) with each well containing the volume correspondent to 10,000 C. albicans cells, different final concentrations (10, 20, or 50 μg/ml) of filter sterilized (Millex-GV 0.22 μm) peptide fractions and Sabouraud broth to the final volume of 100 µl and incubated at 30°C. The control sample was the same, except that the peptide fractions were omitted. As solvent control, the volume of the solvent (2-propanol + TFA) corresponding to the highest volume of the peptide fractions eluted and collected, was submitted to the same procedures of the peptide fractions (freezedried, re-suspended in ultra-pure water, and filter sterilized) and used in the growth inhibition assay. The optical densities were measured at 660 nm using an ELISA reader (DV 990BV6; GDV, Rome, Italy) every 6 h until 36 h, except for the late-night period [40] . The experiments were performed in triplicate and repeated at least twice. The results shown are calculations based on the averages, with the standard deviations, of the read absorbances plotted as a function of time. The inhibition percentages were calculated assuming that the control represents 100% growth according to the formula [100 -(tABS 660 × 100/ cABS 660 )], where tABS 660 was the average absorbance readings at 660 nm of the fraction treated samples at 36 h and cABS 660 was the average absorbance readings at 660 nm of the control sample at 36 h. For the samples that showed an altered growth pattern compared with the control, images of the well bottoms were taken at the end of the experiment to confirm the inhibition effect, and the cells were visualized by an Axioplan.A2 optical microscope (Carl Zeiss do Brazil) at 400× magnification.
Viability assay
The viability assay was performed for the samples with the strongest inhibitory activity against the growth of C. albicans, F4 and F4.7′. For this assay, at the end of the growth inhibition assay, the control cells were washed and diluted 2500 folds with Sabouraud broth. An aliquot of 50 µl from this dilution was spread over the surface of a 12 cm Petri dish with a Drigalski loop containing Sabouraud agar and grown at 30°C for 36 h. At the end of this period, the colonies developed were counted, and the Petri dishes were photographed. The same procedure was followed with cells treated with the F4 or F4.7′ fraction. Results (cell viability loss) are calculated assuming that the control represents 100% viability, according to the formula [100 -(a × 100/b)], where a was the average colony forming unit of the F4 or F4.7′ treated sample and b was the average colony forming unit of the control sample. The experiments were carried out in duplicate.
Amino acid sequence analysis
The peptide with the strongest activity against C. albicans was selected for amino acid sequence analysis. For sequencing, the peptide present in the fraction with the strongest activity against C. albicans, after the second chromatographic step, was freeze-dried and then directly used for sequencing. The N-terminal amino acid sequence of the sample (5 pmol) was determined by Edman degradation carried out in a Shimadzu PSQ-23A protein sequencer (Shimadzu do Brazil). PTHamino acids were detected at 269 nm after separation on a reversedphase C18 column (250 mm × 4.6 mm) under isocratic conditions according to the manufacturer's instructions. Percentage sequence identity with other proteins was searched for automatic alignment, performed using the NCBI-BLAST search system (National Center for Biotechnology Information) [41] , and the chosen sequences were aligned using Clustal Omega set at default parameters [42] . Some sequences without a defined signal peptide were analyzed by SignalP 4.1 [43] .
Plasma membrane permeabilization assay
Plasma membrane permeabilization was measured by Sytox green (Life Technologies do Brazil, São Paulo, Brazil) uptake, according to the instruction manual. This dye fluoresces after interaction with nucleic acids and only penetrates cells with integrity-compromised membranes. At the end of the growth inhibition assay, 100 μl aliquots of C. albicans cells that were grown in the presence of the strongest peptide were suspended and incubated with 0.2 µM Sytox green in 96-well microplates for 15 min at 25°C with periodic agitation and then transferred to glass slides treated with poly-L-lysine. A negative control (no fraction addition) was prepared to evaluate the basal membrane permeability. Observations were made using an Axioplan.A2 differential interference contrast microscope (Carl Zeiss do Brazil) at 400× magnification equipped with a fluorescence filter set for fluorescence detection (excitation wavelengths, 450-490 nm; emission wavelength, 500 nm). The percentage of fluorescent cells, an indication of membrane permeabilization, was determined by counting cell number in random fields of the bright field and fluorescent views for each sample (n = 5). The total cell number in the bright field of each sample was assumed as 100%.
Reactive oxygen species assay
The induction of reactive oxygen species (ROS) was measured using the fluorescent probe 2′,7′-dichlorofluorescein diacetate (H2DCFDA), according to the instruction manual. This dye only became fluorescent after deacetylation by intracellular esterases and oxidation by ROS. This assay was performed as described for the Plasma membrane permeabilization assay with the following alterations: the probe final concentration was 20 µM. The percentage of fluorescent cells was also determined.
Mitochondrial functionality assay
The mitochondrial functionality was measured by the fluorescent probe Mitotracker green (Life Technologies do Brazil) according to the instruction manual. This fluorescent dye passively diffuses across the membrane and accumulates in active mitochondria. Mitochondrial functionality loss is visible as a decrease in the fluorescence signal. This assay was conducted as described for the Plasma membrane permeabilization assay with the following alterations: the probe final concentration was 1 nM. The percentage of fluorescent cells was also determined.
Statistical analysis
Data were submitted to Tukey's test. Calculations were done with Prism software (version 5.0).
Results
Extraction and purification of AMP-rich fractions from L. pisonis seeds
The crude protein extract from L. pisonis seeds was separated into 13 fractions on a C18 reversed-phase column. From these fractions, the first was eluted in the solvent composed of 0.1% TFA and named the non-retained fraction (nr). The other 12 fractions, named F1-F12, were retained on the C18 column and were eluted in the 2-propanol gradient (Fig. 1A) .
All these fractions were visualized by tricine gel electrophoresis, and all contained peptides (except the nr fraction). F1 fraction showed three protein bands of ∼3, 6.2, and 7 kDa; F2 showed one strong protein band of ∼7 kDa; F3 fraction showed two protein bands of ∼7 (strong) and 12 kDa; F4 fraction showed three protein bands of ∼6, 12 (faint), and above the 16.9 kDa marker (faint); F5 fraction showed one major protein band of ∼6 kDa and several faint bands ranging from 12 to above the 16.9 kDa marker; F6 fraction showed four protein bands of 5 (faint), 7, 15 (faint), and 17 kDa; F7 fraction showed two protein bands of ∼6.2 and 9 (strong) kDa; F8 fraction showed three strong protein bands of ∼7, 9, and 14 kDa; F9 fraction showed six protein bands of ∼6.2, 7 (faint), 9, 12, 15 (faint), and 17 (faint) kDa; F10 fraction showed one faint protein band of ∼9 kDa; F11 fraction showed one major protein band of ∼9 kDa and several faint protein bands ranging from 11 to above the 16.9 kDa marker; F12 fraction showed several protein bands ranging from 7 to above the 16.9 kDa marker (Fig. 1B) .
Anti-Candida activity of AMP-rich fractions from L. pisonis seeds
The fractions were tested for antimicrobial activity against C. albicans.
Only the F4, F6, and F11 fractions had activity against the yeast ( Table 1) . Results are presented only for the fractions that showed inhibitory activity or altered growth pattern. The samples treated with the solvent control did not show significant difference compared with the control (data not shown). Fractions F10 and F12 did not inhibit C. albicans significantly; however, the growth of C. albicans treated with these fractions was visually different ( Fig. 2A) , and pseudohyphae formation was observed (Fig. 2B) .
Based on the strongest antimicrobial activity of F4, at the end of the growth inhibition assay, C. albicans cells treated with this fraction were washed and plated on Sabouraud agar. This fraction induced a viability loss of 94.9% in C. albicans cells (Fig. 3A,B) , indicating that the inhibitory effect was candidacidal.
Final purification of AMP from L. pisonis seeds Because it had the strongest antimicrobial activity and fraction homogeneity, we chose the F4 fraction for further purification. However, this fraction was obtained in low quantities. The F4 fraction was rechromatographed in the same reversed-phase column, with a different gradient developed for better separation of the peptides. This method produced seven fractions, named fractions F4.1-F4.7 (Fig. 4A) . Under electrophoretic visualization, fractions F4.1-F4.5 showed faint protein bands of high molecular mass. Only fractions F4.6 and F4.7 contained a strong peptide band of ∼6 kDa (Fig. 4B) . Based on the distinct peak obtained from the C18 column at ∼51 min, its sharpness, its collection mode including the increase (F4.6) and decrease (F4.7) of the peak, with homogeneity observed at electrophoresis (both with only one band of ∼6 kDa), we combined fractions 4.6 and 4.7, and called the combination the F4.7′ fraction. The antimicrobial growth assay on C. albicans cells revealed that the F4.7′ fraction inhibited growth by 38.5% (Fig. 5) and induced a 69.3% loss of viability in C. albicans cells (Fig. 6A,B) . The other fractions did not show any significant inhibitory activity against this yeast (data not shown).
Characterization by amino acid sequence
Because the strongest biological activity of C. albicans inhibition was detected in the F4.7′ fraction, this fraction was selected for additional antimicrobial activity assay and peptide sequencing. The purification process was repeated to accumulate more peptide. The sequence of 6 kDa peptide from L. pisonis was obtained directly from the purified fraction (combination of F4.6 and F4.7 fractions from the C18 column). This fraction contained a peptide from which 36 amino acid residues were obtained with a very good sequence quality, which confirms that this fraction was purified. Sequence comparisons in protein data bank indicated a high similarity with peptides of the plant defensin family (Fig. 7) . The peptide was similar to plant defensins from trees, with 77.7% identity with the defensin from Eucalyptus grandis, 75.0% with the defensin from Panax ginseng, and 72.2% with the defensin from Malus domestica. The peptide also had 75% identity with defensin from the legume Vigna unguiculata. The 36 amino acid residues obtained encompass 80% of the complete amino acid residues of plant defensins, taking the extension of 45 residues of this peptide family into consideration [17] . Based on this analysis, the peptide was renamed L. pisonis defensin 1 (Lp-Def 1 ).
Membrane permeabilization activity of Lp-Def 1
The antimicrobial effect of Lp-Def 1 was characterized in regard to its mechanism of action. At 36 h of the growth inhibition assay, C. albicans cells were tested for membrane permeabilization with the fluorescent dye Sytox green. Fluorescent cells were visualized in the sample-treated cells and the control cells. To confirm permeabilization, the cells were counted in control cell and sample-treated cells, and the percentage of fluorescent cells was assessed. This analysis indicated that the number of fluorescent cells in the sample-treated cells was 15.6%, less than the control cells (23.2%) (Fig. 8A,B) . However, these values were not statistically different. This result indicates that Lp-Def 1 did not permeabilize the plasma membrane of C. albicans after 36 h of incubation.
ROS induced by Lp-Def 1
Candida albicans cells treated with Lp-Def 1 were tested for the induction of ROS using the fluorescent dye H2DCFDA. More fluorescent cells were observed in the sample-treated cells (Fig. 9A) , and this observation was confirmed by determining the percentage of fluorescent cells, 9.5% in sample-treated cells and 2.3% in control cells (Fig. 9B) . However, these values were not statistically different, indicating that ROS was not induced by Lp-Def 1 in C. albicans cells after 36 h of incubation.
Mitochondrial functionality loss induced by Lp-Def 1
Candida albicans cells treated with Lp-Def 1 were also tested for mitochondrial functionality with the fluorescent dye Mitotracker green. Different from other dyes, whereas loss of fluorescence indicates a positive result, the Lp-Def 1 -treated cells showed less fluorescent cells and a weak fluorescent signal (Fig. 10A) . This observation was confirmed by determining the percentage of the fluorescent cells, 79.4% and 27.4%, to control cells and sample-treated cells, respectively (Fig. 10B) . These values were statistically different, indicating that mitochondrial functionality loss was induced by Lp-Def 1 in C. albicans cells after 36 h of incubation. We interpreted the number of 79.4% of fluorescent cells in the control of mitochondrial functionality assay as the same case of the 23.2% of fluorescent cells in the control of membrane permeabilization assay. They complement each other in the sense that ∼20.6% of cells with inactive mitochondria and ∼23.0% of cells with permeabilized membranes, which possibly indicated dead cells. These results are coherent with each other and indicate that it is an inherent condition to the assay.
Discussion
In this study, we searched for AMPs in the wild arboreal plant species L. pisonis that could specifically inhibit the opportunistic yeast pathogen C. albicans. Of the 12 fractions obtained from the peptide extraction of L. pisonis seeds, 3 fractions had antimicrobial activity against C. albicans. The F4, F6, and F11 fractions inhibited C. albicans and this yeast treated with the F10 and F12 fractions had a different growth pattern; among them, the F4 fraction had the strongest activity at the lowest concentration ( Table 1) .
With regard to C. albicans treated with the F10 and F12 fractions, it had a different growth pattern. Microscopic observation of these cultures revealed the presence of pseudohyphae, primarily in cells treated with the F12 fraction. This effect has been demonstrated in Candida species treated with other AMPs, such as a plant LTP [46] , and the plant defense protein 2S albumin [47] . Based on the altered cell morphology due to pseudohyphae induction, we speculate that the poor growth inhibition associated with these fractions may arise from alterations in light absorption by the pseudohyphae in comparison with the yeast morphology. The method described in the growth inhibition assay was originally developed in filamentous fungi [40] and we have adapted it to yeasts. Especially for members of the Candida genus which are dimorphic species [48] , when the morphological transition is induced by an antimicrobial agent, there is an alteration of the growth curve [46] . In general, the incubation of C. albicans cells in the presence of serum, neutral pH, N-acetyl-D-glucosamine, 5% CO 2 , among others, induces pseudohyphae formation [48] . However, the process induced by AMP is currently unknown.
Although the growth inhibition assay was unable to demonstrate an inhibitory effect of the F10 and F12 fractions, we were able to monitor the inhibition visually by inspecting the well bottom of the microplate and observe the differentiated morphology of the yeast growth pattern (Fig. 2A) . This effect could be used to monitor substances that cause morphological transitions in Candida. The antimicrobial effect can also be monitored by microscopic observations (Fig. 2B) . Comparative alignment of the partial N-terminal amino acid sequence of the 6 kDa peptide (F4.7′ fraction) purified from L. pisonis seeds with defensins from different plant species The amino acid sequences that composes the N-terminal signal peptide and the C-terminal domain were excluded from the alignment. Sequences were obtained from BLAST and aligned using Clustal Omega. The conserved Cys residues are highlighted in boxes. The two cysteines belonging to CSαβ motif [44] are indicated in gray. 'I' represents the percentage of identical amino acids residues, which are displayed in bold; 'P' represents the percentage of positive amino acids residues, which are displayed in gray and italics. The numbers above the sequence indicate the peptide size in amino acids with numbering based on the D of L. pisonis peptide. The numbering flanking the sequences represents the size of the mature peptide. The sequences are: P. ginseng (gb AFE88173.1), P. persica (gb AAL85480.1), E. grandis (gb KCW85903.1), M. domestica (gi 657993650), Jatropha curcas (gb ACS96442.1), V. unguiculata (gb ACN93800.1), Clitoria ternatae (Ct-AMP 1 [45] ), Dhalia merckii (Dm-AMP 1 , according to [45] ), and Heuchera sanguinea (Hs-AMP 1 [45] ). The F4 fraction, which had the strongest activity at the lowest concentration, reduced the viability of C. albicans cells by 94.9% at 10 μg/ml (Fig. 3B) . As this initial test indicates, high activity is very desirable for a therapeutic substance, not only to treat immunecompromised patients [49] , but also to reduce the risk of the development of drug resistance [50] . This fraction was submitted to a new round of purification by reversed-phase chromatography in a C18 column with a different 2-propanol gradient which resulted in seven new fractions, called F4.1-F4.7 (Fig. 4A,B) . F4.6 and F4.7 were combined to form F4.7′. Only F4.7′ fraction has the ability to induce viability loss of C. albicans by 69.3% (Fig. 6B) . The ∼6 kDa peptide from the F4.7′ fraction was subject to N-terminal amino acid sequencing. The resulting sequence had a high similarity to plant defensins [17] (Fig. 7) . Thus, we named this peptide Lp-Def 1 .
Our results indicated that Lp-Def 1 inhibits the growth of C. albicans and that this inhibition is due to a candidacidal effect (Fig. 6A,B) . We investigated the possible mechanism of action that lies behind this candidacidal effect at 36 h of incubation of C. albicans cells in the presence of Lp-Def 1 . The membrane permeabilization, ROS induction, and mitochondrial functionality were analyzed the presence or absence of Lp-Def 1 . Our results indicated that after 36 h of incubation with Lp-Def 1 , C. albicans cells showed mitochondrial functionality loss (Fig. 10A,B) but did not show membrane permeabilization (Fig. 8A,B) or ROS induction (Fig. 9A,B) . The precise cascade of events that occur after AMP interaction with a microorganism, which lead to cell death, is not completely understood. When we consider the general characteristics of AMPs and the partially known mechanism of action of some AMPs and overlay these with our results, we can propose a picture that emerges from this theoretical analysis as follow: it is known that AMPs are amphipathic molecules which can interact with biological membranes [51] . Initially, the interaction occurs by charge attraction between the AMP hydrophilic face and a negatively charged molecule of the microorganism membrane, usually negatively charged phospholipid heads [52] . In the second stage, the AMP hydrophobic face is reoriented to the hydrophobic membrane core and AMP thus inserts itself into the membrane. The membrane insertion may occur with some degree of oligomerization of the AMP [53] . Although the model is well understood for peptides that adopt an α-helix configuration and for bacterial membranes, it may be applied to other AMPs not configured in an α-helix scaffold and eukaryotic microorganisms because many non-α-helical AMPs, including plant defensins [54, 55] , also contain an amphiphilic scaffold [56, 57] , and interaction with membranes has been reported [58] . AMP amphipathicity seems to be a universal physicochemical character that can be loaned to other molecules, thereby endowing them with antimicrobial activity [59] . This idea is in agreement with several reports which demonstrate that plant defensins can interact and permeabilize the fungi membrane [60] [61] [62] , similar to many other AMPs [53] . In our results, we can assume that in the first moment Lp-Def 1 interacts with C. albicans cells probably with fungal plasma membrane due to its amphipathicity and charge, because this interaction triggers cellular effects that we observed, e.g. mitochondrial functionality loss and candidacidal activity. The permeabilization event was not observed after 36 h of incubation and reports from literature prompt us to propose two reasons. First, because some AMPs can cause microbial inhibition without provoking membrane permeabilization as exemplified by the interaction of apidaecin (from honeybees) and Escherichia coli [63] , histatin 5 (AMP from human saliva) and C. albicans [64] , human β-defensin 2 and C. albicans [65] , and a plant defensin (AMP from Adenanthera pavonina) and C. albicans and Saccharomyces cerevisiae [66] . Second, because membrane permeabilization provoked by some AMPs can be a transient process that occurs when the peptide enters the cell [67] . Following the interaction, one direct consequence of the membrane structural damage after AMP interaction is the loss of integral membrane potential. Dissipation of the integral membrane potential is part of the mechanism of action of some AMPs [68, 69] . In addition, the membrane potential is necessary for some AMPs to exert their toxic effect, as shown by depolarizing agents that protect cells from AMP toxicity [70, 71] . Restoration of the membrane potential demands energy and consumption of intracellular ATP can lead to energy depletion state. The membrane depolarization by magainin (AMP from amphibian skin) in prokaryotes can halt the ATP synthesis [72] . In eukaryotes, the interaction of temporin (AMP from amphibian skin) can decrease intracellular ATP concentration in Leishmania [73] . To supply cell energy, aerobic respiration must be activated to avoid cell death. Thus, a side effect of the process is seen as ROS production. ROS production is, in general, associated with normal aerobic respiration [74] . Therefore, cells develop many mechanisms to cope with oxygen toxicity under this normal condition [74] . Many stress stimuli are known to lead to an unbalanced physiological state between the prooxidant and antioxidant pathways, favoring the former. In the model yeast S. cerevisiae, stress stimuli such as xenobiotics [75] , oxygen peroxide [76] , acetic acid [77] , cadmium [78] , and AMPs [53] induce ROS. Although our results did not show any ROS induction, we suggest that this result may be due to the assay was carried out at the 36 h of interaction of C. albicans cells with Lp-Def 1 . At this time, 70.1% of the cells in the culture are dead ( Fig. 6A,B) and their structural membrane integrity is lost. ROS and NO can diffuse from dead cells [79] . This can lead to the weak florescent cells at 36 h after interaction of C. albicans cells with Lp-Def 1 .
After the interaction, some AMPs have been demonstrated to enter the cell cytoplasm [67] where they can interact with intracellular targets. One of these possible targets is the mitochondrion. Mitochondria are the foremost organelles in eukaryotic cells, acting as tiny energy factories that supply cell with energy. Today, it is accepted that the mitochondrion is originated from an ancient partnership with α-proteobacteria [80] . Owing to its prokaryotic origin, the mitochondrion shares physiological communalities with bacteria [81] . Many AMPs have been reported to inhibit bacteria [82] [83] [84] , as well as to interact with and impair mitochondrial function [85, 86] . The wellstudied AMPs, such as histatin 5 [87] and lactoferrin (AMP from bull) [88] , target to the mitochondria of C. albicans cells as part of their inhibitory effect. Therefore, we have demonstrated that the mitochondrial functional loss is involved in the candidacidal effect of Lp-Def 1 .
In conclusion, we have purified a biologically active peptide that has strong inhibitory effect against the opportunistic yeast C. albicans. The candidacidal activity could be related to mitochondrial functionality loss. This peptide has a molecular mass of ∼6 kDa with high similarity to plant defensins and is named Lp-Def 1 . The results presented in this work, reinforced by the low toxicity of the plant defensin family toward mammalian cells, indicate the potential of using plant defensins, particularly Lp-Def 1 , as new anti-candida substances. In addition, this study also highlights Brazilian flora as sources of diverse bioactive molecules, which adds value to the species and encourages their conservation, management, and sustainable use. 
